NCT03520855

Brief Summary

The aim of this study is to evaluate the contribution of a serious game in the reinforcement of knowledge acquired during therapeutic education of type 1 diabetes paediatric patients. This evaluation will take place within 3 months of the diagnosis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 27, 2018

Completed
14 days until next milestone

First Posted

Study publicly available on registry

May 11, 2018

Completed
11 months until next milestone

Study Start

First participant enrolled

April 3, 2019

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2023

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 27, 2024

Completed
Last Updated

March 31, 2026

Status Verified

March 1, 2026

Enrollment Period

4.4 years

First QC Date

April 27, 2018

Last Update Submit

March 26, 2026

Conditions

Keywords

Type 1 DiabetesPaediatrics patients

Outcome Measures

Primary Outcomes (1)

  • Diapason questionnaire (Aide aux Jeunes Diabètes)

    50 questions (disease, treatment, food,…)

    3 months

Secondary Outcomes (5)

  • HbA1c dosage

    3 months

  • Number of hypo or hyperglycaemia

    3 months

  • Evaluation of self-care skills

    3 months

  • Evaluation of well-being with WHOFIVE

    3 months

  • Evaluation of well-being with DQOLY

    3 months

Study Arms (2)

ETP + Serious game

EXPERIMENTAL

patients receiving the serious game additionally to the classic therapeutic education

Other: Serious gameBehavioral: ETP

ETP

ACTIVE COMPARATOR

patients under classic therapeutic education

Behavioral: ETP

Interventions

DIVE software will be accessible via internet, children and parents will have to their disposition a room at the hospital specifically to work on the software. The DIVE software is organized in chapters, each matches an item of the therapeutic education process and ends with a knowledge assessment. The child has to end every chapter and succeed every evaluation to pursue on the next chapter. Measures will be taken in order to avoid contamination bias between groups. Children will have to connect to DIVE 2 times per week for a time duration of at last 1 hour.

ETP + Serious game
ETPBEHAVIORAL

Initial therapeutic education only will be applied in this group, with the help of doctors and nurses, based on theoretical educational lessons, reported on the AJD book. Health education sessions will also be taught by nurses.

ETPETP + Serious game

Eligibility Criteria

Age10 Years - 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Child aged from 10 to 17 and 8 months
  • Child with internet access and with a computer or a tablet or a mobile phone in at least one of the two parents or legal representative(s)
  • Informed consent signed by parents or legal representative(s) (only one parent possible)
  • Beneficiary of a social security system

You may not qualify if:

  • No internet access or no computer or no tablet or no mobile phone at home available
  • No French language proficiency of the infant or legal representative(s)
  • Inability to understand the game's instructions
  • Inability to understand or fill the consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Necker Hospital

Paris, Paris, 75015, France

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 1

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Study Officials

  • Jacques BELTRAND, MD, PhD

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 27, 2018

First Posted

May 11, 2018

Study Start

April 3, 2019

Primary Completion

August 30, 2023

Study Completion

November 27, 2024

Last Updated

March 31, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations